Fatigue · women with usual‐type vulval intraepithelial neoplasia
Summary of findings for imiquimod probably leads to higher fatigue ‐ any grade compared with cidofovir (moderate certainty).
1 finding from 1 review
Headache · women with usual‐type vulval intraepithelial neoplasia
Summary of findings for imiquimod probably leads to higher headache ‐ any grade compared with cidofovir (moderate certainty).
1 finding from 1 review
Total serious adverse events · women with usual‐type vulval intraepithelial neoplasia
Summary of findings for imiquimod showed no clear difference in total serious adverse events compared with cidofovir (moderate certainty).
1 finding from 1 review
Treatment discontinuation · women with usual‐type vulval intraepithelial neoplasia
Summary of findings for imiquimod showed no clear difference in treatment discontinuation compared with cidofovir (moderate certainty).
1 finding from 1 review
Intervention not reported
Laser vaporisation versus CUSA · women with usual‐type vulval intraepithelial neoplasia
The intervention showed no clear difference in laser vaporisation versus CUSA (low certainty).
1 finding from 1 review
Complete response · women with usual‐type vulval intraepithelial neoplasia
Summary of findings for imiquimod leads to higher response to treatment at 5 to 6 months ‐ complete response compared with placebo (high certainty).
2 findings from 1 review
Response to treatment at 12 months ‐ overall response · women with usual‐type vulval intraepithelial neoplasia
Summary of findings for imiquimod probably leads to higher response to treatment at 12 months ‐ overall response compared with placebo (moderate certainty).
1 finding from 1 review
Progression to vulval cancer at 12 months · women with usual‐type vulval intraepithelial neoplasia
Summary of findings for imiquimod showed no clear difference in progression to vulval cancer at 12 months compared with placebo (low certainty).
1 finding from 1 review
HPV DNA persistence · women with usual‐type vulval intraepithelial neoplasia
Summary of findings for imiquimod leads to lower HPV DNA persistence compared with placebo (high certainty).
1 finding from 1 review
Pain ‐ Any grade · women with usual‐type vulval intraepithelial neoplasia
Summary of findings for imiquimod leads to higher pain ‐ any grade compared with placebo (high certainty).
1 finding from 1 review
Dose reductions · women with usual‐type vulval intraepithelial neoplasia
Summary of findings for imiquimod leads to higher dose reductions compared with placebo (high certainty).
1 finding from 1 review
Response to treatment at 6 months ‐ overall response · women with usual‐type vulval intraepithelial neoplasia
Summary of findings for imiquimod showed no clear difference in response to treatment at 6 months ‐ overall response compared with cidofovir (moderate certainty).
1 finding from 1 review
Patient‐reported pain intensity or pain relief (VAS, NRS or categorical scale) · patients with lumbar stenosis
It is very uncertain whether SUMMARY OF FINDINGS FOR DECOMPRESSION changes pain Long‐term (≥ 12 months) Pain scores converted to 0 to 100 scale… compared with FUSION (very low certainty).
1 finding from 1 review
Reoperation · patients with lumbar stenosis
SUMMARY OF FINDINGS FOR DECOMPRESSION leads to lower reoperations Number of patients requiring a revision surgery compared with INTERSPINOUS SPACERS (high certainty).
1 finding from 1 review
Patient‐reported pain intensity or pain relief (VAS, NRS or categorical scale) · patients with lumbar stenosis
SUMMARY OF FINDINGS FOR FUSION showed no clear difference in pain Long‐term (≥ 12 months) Pain scores converted to 0 to 100 scale… compared with INTERSPINOUS SPACERS (low certainty).
1 finding from 1 review
Disability Long‐term (≥ 12 months) Disability scores converted to 0 to 100 scale to allow for comparison of different disability scales (RMDQ, ODI, JOA) · patients with lumbar stenosis
SUMMARY OF FINDINGS FOR FUSION may leads to higher disability Long‐term (≥ 12 months) Disability scores converted to 0… compared with INTERSPINOUS SPACERS (low certainty).
1 finding from 1 review
Operating time · patients with lumbar stenosis
It is very uncertain whether SUMMARY OF FINDINGS FOR FUSION changes operation time Duration of operation reported in minutes compared with INTERSPINOUS SPACERS (very low certainty).
1 finding from 1 review
Total operative and perioperative blood loss (mL) ( · patients with lumbar stenosis
SUMMARY OF FINDINGS FOR FUSION probably leads to higher blood loss Amount of perioperative blood loss reported in mL compared with INTERSPINOUS SPACERS (moderate certainty).
1 finding from 1 review
Reoperation · patients with lumbar stenosis
SUMMARY OF FINDINGS FOR FUSION showed no clear difference in reoperations Number of patients requiring a revision surgery compared with INTERSPINOUS SPACERS (high certainty).
1 finding from 1 review
Disability Long‐term (≥ 12 months) Disability scores converted to 0 to 100 scale to allow for comparison of different disability scales (RMDQ, ODI, JOA) · patients with lumbar stenosis
It is very uncertain whether SUMMARY OF FINDINGS FOR DECOMPRESSION changes disability Long‐term (≥ 12 months) Disability scores converted to 0… compared with FUSION (very low certainty).
1 finding from 1 review